The genes coding for apolipoproteins (apo) AI, CIII, and AIV, designated APOA1, APOC3, and APOA4, respectively, are closely linked and tandemly organized in the long arm of the human chromosome 11. A DNA rearrangement involving the genes encoding apoAI and apoCIHl in certain patients with premature atherosclerosis has been associated with deficiency of both apoAI and apoCIll in the plasma of these patients. Structural characterization of the genes for apoAI and apoCIII in one of these patients indicates that this rearrangement consists of a DNA inversion containing portions of the 3' ends of the apoAI and apoCHIl genes, including the DNA region between these genes. The breakpoints of this DNA inversion are located within the fourth exon of the apoAI gene and the first intron of the apoCIHi gene. Thus, this DNA inversion results in reciprocal fusion of the apoAI and apoCIll gene transcriptional units. Expression of these gene fusions in cultured mammalian cells results in stable mRNA transcripts with sequences representing fusions of the apoAI and apoCIl mRNAs. These results indicate that absence of transcripts with correct apoAl and apoCIll mRNA sequences causes apoAI and apoCIII deficiency in the plasma of these patients and suggest that these apolipoproteins are involved in cholesterol homeostasis and protection against premature atherosclerosis. (4, 5) . A less prominent protein constituent of HDL is apolipoprotein CIII (apoCIII), which is actively exchanged between HDL and triglyceride-rich lipoprotein particles and appears to inhibit both the hydrolysis of these particles by the enzyme lipoprotein lipase and the apolipoprotein E (apoE)-mediated uptake of remnants of these particles by the liver (3).
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Noncovalent association of lipids with certain plasma proteins (apolipoproteins) results in formation of lipid-protein complexes (lipoproteins), the major carriers of lipids in the plasma. The concentration of high density lipoprotein (HDL) in the plasma is inversely correlated with the risk for coronary artery disease (1) . HDL promotes cholesterol efflux from cells (reverse cholesterol transport) and by this process may protect against atherosclerosis (2) . The major protein constituent of HDL is apolipoprotein Al (apoAI) derived from the liver and from the surface of lymph triglyceride-rich lipoprotein particles (chylomicrons) during hydrolysis of these particles upon their entry in the circulation (reviewed in ref. 3 ). In addition, apoAl activates lecithin:cholesterol acyltransferase, an enzyme thought to play a key role in reverse cholesterol transport (4, 5) . A less prominent protein constituent of HDL is apolipoprotein CIII (apoCIII), which is actively exchanged between HDL and triglyceride-rich lipoprotein particles and appears to inhibit both the hydrolysis of these particles by the enzyme lipoprotein lipase and the apolipoprotein E (apoE)-mediated uptake of remnants of these particles by the liver (3) .
The genes coding for apoAl, apoCIII, and another apolipoprotein, apolipoprotein AIV (apoAIV), are closely linked and tandemly organized in the long arm of human chromosome 11 (6) and are designated APOAI, APOC3, and APOA4, respectively. It has been shown recently that the organization of these genes in the rat is remarkably similar to that in humans, and it was proposed that these genes are similarly organized in the genomes of all mammals (7).
Previous studies indicated that an inherited DNA rearrangement involving the genes for apoAl and apoCIII but not the gene for apoAIV in certain patients with premature atherosclerosis is associated with deficiency of apoAI, apo-CIII, and HDL in the plasma of these patients (8) (9) (10) . This report shows that the DNA rearrangement in the genome of one of these patients is due to inversion of a 6.0-kilobase (kb) DNA segment containing portions of the 3' sequences in the genes for apoAI and apoCIII including the DNA region between these genes. Because of the close physical linkage and convergent transcription of these genes in the normal human genome (6) (11, 12) . Screening of these libraries, purification of positive clones, and preparation of clone DNA were carried out as described (12) . Hybridization probes were prepared using cloned DNA fragments as detailed (13) . DNA restriction mapping was carried out by digestion with various restriction enzymes (New England Biolabs), electrophoresis in 1% agarose gels, transfer onto nitrocellulose filters, and hybridization with various DNA probes (14) . Heteroduplex mapping was carried out by the formamide-spreading technique (15) .
Nucleotide-Sequencing Determinations. DNA sequencing was carried out by subcloning relevant DNA fragments in bacteriophage M13 vectors (16) and using the resulting single-stranded DNA templates for nucleotide sequencing by the dideoxy-chain-termination method (17) .
Plasmid Constructions, Transfection of Gene Constructs into Mammalian Cells, RNA Hybridization, and S1-Nuclease and Primer-Extension Analyses. An -250-base-pair (bp) HincIIPvu II DNA fragment containing the 72-bp and 21-bp repeats of the simian virus 40 (SV40) enhancer but not the "TATA box" of the early promoter of this virus was ligated by using Abbreviations: apoAl, apoCIII, and apoAIV, apolipoproteins Al, CIII, and AIV; HDL, high density lipoprotein; SV40, simian virus 40.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (20, 21) . Forty-eight hours after transfection, these cells were harvested and used to prepare total RNA (22) . This RNA was used for blotting and hybridization and for Si-nuclease and primer-extension analyses (23) (24) (25) . These results show that the arrangement of DNA segments with hybridization homology to these probes in XB7 is I-III-II-IV (Fig. iC) , while that in the normal human genome is 1-II-III-IV (Fig. 1A) . Therefore, a DNA segment containing sequences homologous to probes II and III is inverted in the genome of the apoAl/apoCIll-deficient patient. Comparison of the restriction map of XB7 ( Fig. 1C) with that of the normal human genome (Fig. 1A) indicates that this DNA inversion is 6.0 kb long and that it contains portions of the 3' sequences in the apoAl and apoCIII genes including the DNA region between these genes. This comparison also shows that the organization of the remaining 5' portions, promoter, and 5' flanking regions of these genes is not affected by this DNA inversion.
RESULTS

Inversion
The DNA Inversion Is Confined Within the apoAl-apoClIl Gene Region. A clone (XJ5) containing the apoAl and apoCIII genes in their normal arrangement (see Fig. 1A ) was isolated from a genomic library constructed with DNA from blood taken from a normal (with regard to coronary artery disease) donor. This clone contains 8.5 kb and 2.5 kb of the 5' flanking (27) regions of the apoAl and apoCIII genes, respectively (data not shown). The clone XB7 contains 6.5 kb and 5.0 kb of the 5' flanking regions of the apoAl and apoCIII genes, respectively (Fig. 1C) . The DNA inserts in these clones have the same orientation with respect to the arms of the cloning vector. Comparison of the structure of these clones by heteroduplex mapping shows that, with the exception of the 6.0-kb DNA inversion in clone XB7, the remaining sequences are very similar between these clones (Fig. 2) . These results indicate that the DNA inversion is confined within the apoAl-apoCIII gene region of these patients.
The DNA Inversion Results in Reciprocal Fusion of Portions of the apoAI and apoCIII Genes. The sequences at the junctions ofthe DNA inversion in clone XB7 were determined (Fig. 1E) . The results show that as a consequence of this DNA inversion, the 3' end of a portion of the apoAl gene exon 4 (26) is linked to the 5' end of a portion of the apoCIII gene intron 1 (27) , while the 3' end of a portion of the apoCIII gene intron 1 is linked to the 5' end of a portion of the apoAl gene exon 4 (Fig. 1D) . The sequences flanking the junctions of this DNA inversion were aligned and compared with the corresponding sequences in the normal human genome. This comparison shows that 9 nucleotides in the apoAl gene exon 4 (AGACAGAGG) and 21 nucleotides in the apoCIII gene intron 1 (CCCAGTCCTACCCCAGACAGG) have been deleted in clone XB7 (Fig. 3) . Therefore, this DNA inversion results in fusion of nucleotide 1 in codon 78 of the message translated into the mature apoAl amino acid sequence with nucleotide 305 in the apoCIII gene intron 1 (apoAl-apoCIII fusion) and fusion of nucleotide 283 in the apoCIII gene intron 1 with nucleotide 2 in codon 81 of the message translated into the mature apoAl amino acid sequence (apoCIII-apoAl fusion) (Fig. 3) . It also should be noted that translation of the apoAI-apoCIII fusion, according to the frame of apoAl, results in a termination codon (boxed TGA) located two codons 3' to codon 77 in apoAl (Fig. 3) .
Expression of the apoAl-apoCIII and apoClII-apoAl Gene Fusions Results in Stable mRNA Transcripts. Pst I DNA fragments of 2.2 kb and 4.5 kb containing the apoAl and apoCIII genes, respectively, were isolated from clone XJ5 (see Fig. 1A ) and subcloned in the plasmid vector pUC9-SV. Similarly, Pst I DNA fragments of 5.5 kb and 1.4 kb containing the apoAl-apoCIII and apoCIII-apoAl gene fusions, respectively, were isolated from clone XB7 (Fig. 1D) A B (27) . The DNA segment that is inverted in clone XB7 and the corresponding segment in the normal human genome are boxed. The nucleotide sequences deleted in clone XB7 are indicated by stippled boxes.
and subcloned in pUC9-SV. The resulting gene constructs were transfected into monkey kidney COS-1 cells, and total RNA from these cells was studied by blotting and hybridization with probes containing the last exon of the apoAI (probe II) and apoCIII (probe III) genes (Fig. 1A) . The resulting autoradiograms show that expression of the apoAl and apoCIII gene constructs results in mRNAs with sizes very similar to the corresponding mRNAs in adult human liver (Fig. 4) . In contrast, expression of the apoAI-apoClII gene construct results in a mRNA with homology to probe III but not to probe II and a size that is 400-500 nucleotides larger than adult human liver apoCIII mRNA (Fig. 4) . Expression of the apoCIIl-apoAl gene fusion, on the other hand, results in an mRNA with homology to probe II but not to probe III and a size that is 400-500 nucleotides shorter than adult human liver apoAI mRNA (Fig. 4) .
Structure of the apoAI-apoCII and apoCIII-apoAI Gene Fusion Transcripts. Total RNA from COS-1 cells transfected with various apoAI and apoCIII gene constructs was studied by primer extension and Si-nuclease protection. A 121-bp DNA fragment extending from nucleotide 474 through nucleProbe 11 1 (1987) otide 594 in the apoAl gene exon 3 and a 276-bp cDNA fragment spanning 56 bp of exon 3, the entire exons 2 (63 bp) and 1 (17 bp), the TATA box and 29 bp of the 5' flanking region in the apoAI gene (including 23 GC residues), and 59 bp of plasmid pBR322 sequences (26) were used as primerextension and Si-nuclease-protection probes, respectively. The results show that the sizes of nucleotide fragments obtained with RNA from the apoAI-apoCIII fusion are similar to those obtained with RNA from either the apoAI gene construct or adult human liver (Fig. 5 A and B) . In addition, Si-nuclease-protection analysis using as probe a 1260-bp cDNA fragment spanning 265 bp of exon 4, the entire exons 3 (124 bp) and 2 (67 bp), part of exon 1 (16 bp) in the apoCIII gene, and 789 bp of pBR322 sequences shows that the size of the protection fragment obtained with RNA from the apoAI-apoCIII fusion is very similar to that obtained with RNA from either the apoCIII gene construct or adult human liver (Fig. 5C) . However, S1-nuclease analysis using as probe a 2000-bp Sma I DNA fragment spanning 22 bp of the apoCIII gene exon 2, 321 bp of the apoCIII gene intron 1, the entire apoAl gene region in the apoAI-apoCIII fusion, and 250 bp of SV40 sequences indicates that only RNA from the apoAlapoCIII fusion protects a 450-nucleotide-long fragment (Fig.  5D ). These results indicate that the transcription start site of the apoAI-apoCIII fusion mRNA is very similar to that of the normal apoAl mRNA and that the apoAl gene introns 1, 2, and 3 and apoCIII gene introns 2 and 3, present in the primary transcript of this fusion, are spliced similarly to the corresponding introns in the normal apoAI and apoCIII genes (Fig.  SF) . These results also show that neither the portion ofapoAl exon 4 nor the portion ofapoCIII gene intron 1 is spliced from the primary transcript of this gene fusion (Fig. 5F ). The structure of the apoCIII-apoAl fusion mRNA was characterized by Si-nuclease mapping using as probe a 325-bp DNA fragment that spans 95 bp of the apoAl exon 4 and 228 bp of apoCIII intron 1 (Fig. SE) . The results show that this RNA protects a 123-nucleotide-long probe fragment (Fig. SE) .
Since the sizes of the apoCIII gene exon 1 and apoAl gene exon 4 in this fusion are 35 bp and 545 bp, respectively, and the size of its mRNA is 500-600 nucleotides long (Fig. 4) , it can be concluded that the start site of this mRNA is similar to that of the normal apoCIII mRNA and that the portion of apoCIll gene intron 1 present in this fusion is spliced via a cryptic 3' splice site (TTCTTCAGGC) located 256 nucleotides 3' to the 5' splice junction of the apoCIII gene intron 1 ( Fig. 5G; ref. 27 ).
DISCUSSION
Reciprocal recombination events leading to DNA inversions are essential for the assembly of functional immunoglobulin and T-cell receptor genes in eukaryotes (28, 29) . The DNA inversion within the apoAI/apoCIII-encoding gene cluster of the apoAl/apoCIII-deficient patients and a similar inversion within the 8-globin gene cluster of certain patients with 8,f3-thalassemia (30) 3.
AI. in stabilization of DNA stem-loop structures necessary for the recombination events that led to these inversions. Alu I repetitive DNA elements have also been implicated in the recombination events that led to two different DNA deletions within the low density lipoprotein receptor gene of certain patients with familial hypercholesterolemia (31) .
Because of the close physical linkage and convergent transcription of the apoAl and apoCIII genes in the normal human genome (6), the DNA inversion in the genome of the apoAI/apoCIII-deficient patients results in reciprocal fusion of portions of the apoAI and apoCIII gene transcriptional units. These gene fusions are expressed into stable mRNAs with sequences representing fusions of the normal apoAI and apoCIII mRNAs. Specifically, the apoAl-apoCIII gene fusion mRNA contains the apoAI gene exons 1, 2, and 3 and part of exon 4 as well as the apoCIII gene exons 2, 3, and 4. In addition, this mRNA contains the entire portion of apoCIII gene intron 1 present in this gene fusion. Therefore, it is interesting that the presence of the apoCIII intron 1 3' splice site and several GT dinucleotides 5 (33) , the normal branch-point sequence for lariat formation is not essential for pre-mRNA splicing in higher eukaryotes.
The codons for initiation of translation of the apoAl and apoCIII mRNAs are located within exon 2 in the corresponding genes (26, 27) . The apoAl-apoCIII gene fusion mRNA contains both these exons. Thus, the initiation codons for apoAl (upstream initiation codon) and apoCIII (downstream initiation codon) are both present in the apoAl-apoCIII fusion mRNA (see Fig. SF ). Translation of this mRNA starting at its upstream initiation codon runs into a termination codon located two codons 3' to codon 77 in apoAl (see Fig. 3 ). In contrast, translation of this mRNA starting at its downstream initiation codon results in the intact normal apoCIII amino acid sequence. However, the apoAl/apoCIII-deficient patients lack apoCIII in their plasma. It is possible that apoCIII is being synthesized in vivo, but disturbance(s) of the lipoprotein metabolism due to the absence of apoAI results in hypercatabolism of this protein. Alternatively, initiation of translation of this mRNA may occur only at its upstream initiation codon. However, it should be pointed out that the presence of a termination codon in frame with the upstream initiation codon may result in translation starting from the downstream initiation codon (34) . On the other hand, the apoCIII-apoAI gene fusion mRNA does not contain any of the natural initiation codons for apoAI and apoCIII. However, the first AUG proximal to the 5' end of this mRNA coincides with codon 86 in apoAl mRNA (26) . This AUG is located within a nucleotide sequence context (AGGAG-AUGA) that may allow its utilization by ribosomes (34) as an initiation codon. Thus, translation ofthis mRNA would result in a protein containing the 86th to 243rd amino acid portion of apoAl. Therefore, this protein would contain the amphipathic amino acid repeats in apoAl (26) but not its signal peptide and may be accumulated and/or degraded intracellularly.
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